Corvus Pharmaceuticals Inc (CRVS)
Stock-Based Compensation
$2.61M
Quarterly · Period ending: · USD
CRVS Stock-Based Compensation
Latest reported$2.61Mperiod ending
Latest reported$2.61Mperiod ending
CRVS Quarterly Stock-Based Comp ($0.00 → $2.61M)
Quarterly stock-based compensation
High-resolution chart · PNG
CRVS stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 2,609,000 | |
| 2,650,000 | |
| 1,574,000 | |
| 1,249,000 | |
| 1,256,000 | |
| 1,251,000 | |
| 845,000 | |
| 701,000 | |
| 768,000 | |
| 689,000 | |
| 572,000 | |
| 546,000 | |
| 537,000 | |
| 492,000 | |
| 620,000 | |
| 658,000 | |
| 675,000 | |
| 739,000 | |
| 738,000 | |
| 1,096,000 | |
| 1,173,000 | |
| 1,225,000 | |
| 1,236,000 | |
| 1,283,000 | |
| 1,383,000 | |
| 1,845,000 | |
| 1,748,000 | |
| 1,749,000 | |
| 1,898,000 | |
| 1,953,000 | |
| 1,805,000 | |
| 1,794,000 | |
| 1,735,000 | |
| 1,801,000 | |
| 1,739,000 | |
| 1,501,000 | |
| 1,521,000 | |
| 1,468,000 | |
| 1,047,000 | |
| 1,264,000 | |
| 1,076,000 | |
| 441,000 | |
| 286,000 | |
| 122,000 | |
| 18,000 | |
| 2,000 | |
| 0 |